PT-141 serves as a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound functions by activating specific receptors throughout the body, causing to augmented sexual function. Research studies have revealed that PT-141 could remarkably address a spectrum of sexual dysfunctio